Cirmtuzumab
Cirmtuzumab, also called UC-961, is a lab-made antibody that targets a protein called ROR1 on cancer cells. It is an experimental cancer drug being tested in early human trials for several cancers, including chronic lymphocytic leukemia (CLL).
This page was last edited on 3 February 2026, at 00:29 (CET).